H. R. 7383, also known as the "Retaining Access and Restoring Exclusivity Act" or the "RARE Act," proposes changes to the Federal Food, Drug, and Cosmetic Act to limit the exclusive approval or licensure of drugs designated for treating rare diseases or conditions. The bill...
Simple Explanation
The bill wants to change the rules for special medicines made for rare diseases, so they can only be used for the specific health problem they were approved for, not the whole disease. It wants these changes to count for all these special medicines, no matter when they were first allowed to be used.